BNTX vs. LLY
Compare and contrast key facts about BioNTech SE (BNTX) and Eli Lilly and Company (LLY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BNTX or LLY.
Performance
BNTX vs. LLY - Performance Comparison
Returns By Period
In the year-to-date period, BNTX achieves a -5.51% return, which is significantly lower than LLY's 24.75% return.
BNTX
-5.51%
-10.78%
10.05%
0.33%
37.95%
N/A
LLY
24.75%
-21.16%
-5.88%
22.90%
46.40%
29.40%
Fundamentals
| BNTX | LLY | |
|---|---|---|
| Market Cap | $25.49B | $777.36B |
| EPS | -$2.08 | $9.24 |
| PEG Ratio | 0.04 | 0.78 |
| Total Revenue (TTM) | $1.74B | $40.86B |
| Gross Profit (TTM) | $1.44B | $33.33B |
| EBITDA (TTM) | -$145.49M | $13.78B |
Key characteristics
| BNTX | LLY | |
|---|---|---|
| Sharpe Ratio | -0.02 | 0.79 |
| Sortino Ratio | 0.29 | 1.28 |
| Omega Ratio | 1.03 | 1.17 |
| Calmar Ratio | -0.01 | 0.96 |
| Martin Ratio | -0.06 | 3.78 |
| Ulcer Index | 16.91% | 6.23% |
| Daily Std Dev | 40.94% | 29.87% |
| Max Drawdown | -82.25% | -68.27% |
| Current Drawdown | -77.41% | -24.62% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between BNTX and LLY is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
BNTX vs. LLY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for BioNTech SE (BNTX) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BNTX vs. LLY - Dividend Comparison
BNTX has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.72%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BNTX BioNTech SE | 0.00% | 0.00% | 1.41% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LLY Eli Lilly and Company | 0.72% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.95% | 2.46% | 2.77% | 2.37% | 2.84% | 3.84% |
Drawdowns
BNTX vs. LLY - Drawdown Comparison
The maximum BNTX drawdown since its inception was -82.25%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for BNTX and LLY. For additional features, visit the drawdowns tool.
Volatility
BNTX vs. LLY - Volatility Comparison
BioNTech SE (BNTX) has a higher volatility of 11.97% compared to Eli Lilly and Company (LLY) at 11.08%. This indicates that BNTX's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
BNTX vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between BioNTech SE and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities